LoginRegister
    Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segmentOmega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment
    Pfizer, Novartis lead USD 2 billion spending spree on gene therapy productionPfizer, Novartis lead USD 2 billion spending spree on gene therapy production
    Cadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects pleaCadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects plea
    Ipca Labs Gujarat facility red-flagged by USFDA for non-compliance with CGMPIpca Labs Gujarat facility red-flagged by USFDA for non-compliance with CGMP
    3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US
    Glenmark diabetes management drug Metformin Hydrochloride ER tablets get USFDA nodGlenmark diabetes management drug Metformin Hydrochloride ER tablets get USFDA nod
    Alembic Pharma gets USFDA nod for generic version of Rapaflo CapsulesAlembic Pharma gets USFDA nod for generic version of Rapaflo Capsules
    Unichem Lab shares jump over 7 pc after USFDA nod for Atenolol tabletsUnichem Lab shares jump over 7 pc after USFDA nod for Atenolol tablets
    Teva Pharma, Israeli institutes sign agreement to boost drug research on cancer treatmentsTeva Pharma, Israeli institutes sign agreement to boost drug research on cancer treatments
    Minister informs Parliament about steps taken to promote affordable generic drugsMinister informs Parliament about steps taken to promote affordable generic drugs
    Novartis strikes USD 9.7 billion deal to acquire cholesterol drugmaker The Medicines CoNovartis strikes USD 9.7 billion deal to acquire cholesterol drugmaker The Medicines Co
    Indoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDAIndoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDA
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X